Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase

Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase

US Patent 8921389 · Granted Dec 30, 2014

Estimated economic value: $23,894,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Enhanced erythropoiesis and iron metabolism2023
Enhanced erythropoiesis and iron metabolism2023
Nitrogen-containing heteroaryl compounds and methods of use thereof2022
Nitrogen-containing heteroaryl compounds and methods of use thereof2022
Enhanced erythropoiesis and iron metabolism2021
Enhanced erythropoiesis and iron metabolism2021
Pharmaceutical formulations of a HIF hydroxylase inhibitor2020
Nitrogen-containing heteroaryl compounds and methods of use thereof2020
Nitrogen-containing heteroaryl compounds and methods of use thereof2020
Crystalline forms of a prolyl hydroxylase inhibitor2019
Crystalline forms of a prolyl hydroxylase inhibitor2018
Nitrogen-containing heteroaryl compounds and methods of use thereof2018